Post Covid-19 Cardiopulmonary and Immunological Changes (covid-19)

Clinical Trial ID NCT04388436

Rank	Title	Journal	Year	PubWeight™‹?›
1	Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.	Lancet	2020	18.32
2	Thrombosis as an intravascular effector of innate immunity.	Nat Rev Immunol	2012	2.98
3	Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome.	Clin Exp Immunol	2004	2.21
4	1-year pulmonary function and health status in survivors of severe acute respiratory syndrome.	Chest	2005	1.45
5	Human immunopathogenesis of severe acute respiratory syndrome (SARS).	Virus Res	2007	1.24
6	Radiology of severe acute respiratory syndrome (SARS): the emerging pathologic-radiologic correlates of an emerging disease.	J Thorac Imaging	2006	0.97
7	Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients.	Radiology	2004	0.85
8	The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors.	Chest	2005	0.80
9	The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status.	Respirology	2010	0.80
10	SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS.	Eur J Clin Invest	2009	0.77
11	Follow-up chest radiographic findings in patients with MERS-CoV after recovery.	Indian J Radiol Imaging	2017	0.75